![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, October 22, 2017 3:24:22 PM
“Most of today’s cell therapy production platforms are based on 2D technologies, such as cell factories or cell stacks,”
Key word being MOST. What are the others and what are they using. I believe Lonza already has the ability to manufacture commercial quantities of cells, so no partnership needed. And besides, you claim only MSC's can be grown in our bioreactor. Can't have it both ways can you?
Sent an email to IR asking if any type of cells can be grown in our bioreactor. No response as of yet. Have yet to have a single question I have ever asked, answered or even an acknowledgment that an email was received. I've emailed both Karine and Efrat on many occasions, but I guess they too, don't want to deal with shareholder questions, just like the twins. But if I do get a response, I will let you know. Not holdimg my breath.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM